Literature DB >> 29661769

Introduction to Nephropharmacology for the Clinician: A New CJASN Series.

Thomas D Nolin1, Mark A Perazella2,3.   

Abstract

Keywords:  Acute Kidney Injury; Chronic; Drug-related Side Effects and Adverse Reactions; Humans; Pharmacodynamics; Pharmacogenetics; Pharmacology; Renal Insufficiency; United States; kidney; kidney disease; nephrology; pharmacokinetics

Year:  2018        PMID： 29661769      PMCID： PMC6032583          DOI： 10.2215/CJN.03180318

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  7 in total

Review 1.  Representation of Patients With Kidney Disease in Trials of Cardiovascular Interventions: An Updated Systematic Review.

Authors:  Ioannis Konstantinidis; Girish N Nadkarni; Rabi Yacoub; Aparna Saha; Priya Simoes; Chirag R Parikh; Steven G Coca
Journal:  JAMA Intern Med       Date:  2016-01       Impact factor: 21.873

Review 2.  Lack of drug dosing guidelines for critically ill patients receiving continuous renal replacement therapy.

Authors:  S L Goldstein; T D Nolin
Journal:  Clin Pharmacol Ther       Date:  2014-05-08       Impact factor: 6.875

3.  Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Gary R Matzke; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Lesley A Inker; Jason G Umans; Patrick Murray
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

Review 4.  Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease.

Authors:  Steven G Coca; Harlan M Krumholz; Amit X Garg; Chirag R Parikh
Journal:  JAMA       Date:  2006-09-20       Impact factor: 56.272

5.  Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.

Authors:  Yi-Wen Chiu; Isaac Teitelbaum; Madhukar Misra; Essel Marie de Leon; Tochi Adzize; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2009-05-07       Impact factor: 8.237

6.  Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney.

Authors:  Balthasar L Hug; Daniel J Witkowski; Colin M Sox; Carol A Keohane; Diane L Seger; Catherine Yoon; Michael E Matheny; David W Bates
Journal:  Kidney Int       Date:  2009-09-16       Impact factor: 10.612

Review 7.  Drug adherence in chronic kidney diseases and dialysis.

Authors:  Michel Burnier; Menno Pruijm; Gregoire Wuerzner; Valerie Santschi
Journal:  Nephrol Dial Transplant       Date:  2014-02-09       Impact factor: 5.992
  7 in total
  1 in total

1.  Adverse Drug Effects in Patients with CKD: Primum Non Nocere.

Authors:  Mark A Perazella; Thomas D Nolin
Journal:  Clin J Am Soc Nephrol       Date:  2020-07-01       Impact factor: 8.237
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.